Lung Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Lung Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating adding berzosertib to standard carboplatin/gemcitabine and to pembrolizumab for patients with advan…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors [Phase 1]
Phase 1 study of palbociclib in combination with gedatolisib in patients with advanced solid tumors, including lung squamous cell carcinoma,…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC [Phase 1]
Phase 1 study evaluating the safety and feasibility of combining pirfenidone with standard first-line chemotherapy in advanced non-small cel…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics reports long-term follow-up data from subjects treated with autologous T cells engineered with a Sleeping Beauty system…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma
A clinical trial evaluating the therapeutic effect of immunotherapy in advanced lung squamous cell carcinoma is currently enrolling by invit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: SHR-1701 Combined With Fluzoparib in Lung Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating SHR-1701 in combination with Fluzoparib for non-small cell lung cancer (lung squamous cell carcinoma).
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy [Phase 2]
Phase 2 clinical trial update evaluating pevonedistat with carboplatin and paclitaxel in advanced non-small cell lung cancer patients previo…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma [Phase 2]
A Phase 2 trial evaluating radiation and gene therapy before nivolumab in metastatic non-small cell lung cancer and uveal melanoma was termi…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: A Study of Endostar Combined With Chemotherapy and Immunotherapy in Lung Squamous Cell Carcinom [Phase 4]
Phase 4 trial update exploring Endostar with chemotherapy and immunotherapy in lung squamous cell carcinoma is reported but current status i…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer [Phase 2]
Phase 2 trial update for Sapanisertib in patients with stage IV or recurrent lung squamous cell carcinoma shows completed status and posted …
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating tislelizumab in combination with chemotherapy as neoadjuvant therapy for stage IIIA-IIIB (N2) lung squamous cell …
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: To Evaluate the Efficacy of Afatinib in Advanced Lung Squamous Cell Carcinoma With EGFR Sensitive Mutation [Phase 4]
Phase 4 clinical trial update evaluating afatinib for advanced lung squamous cell carcinoma with EGFR sensitive mutation.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Apatinib for Advanced Lung Squmamous Carcinoma [Phase 4]
Phase 4 clinical trial update for apatinib in advanced lung squamous cell carcinoma being conducted by Xuzhou Central Hospital.
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
A Mayo Clinic trial update on isolating and testing circulating tumor cells using the ClearCell FX EP+ System in lung cancer; the study stat…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Oral Rigosertib for Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating oral rigosertib for various squamous cell carcinomas has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma [Phase 4]
This Phase 4 clinical trial update reports the study of nedaplatin combined with docetaxel for advanced lung squamous cell carcinoma; the tr…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma [Phase 1]
This document provides an update on a Phase 1 trial evaluating anti-GPC3 CAR T cells for recurrent or refractory lung squamous cell carcinom…
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: A Phase 1 Study in Participants With Advanced Cancer [Phase 1]
A Phase 1 trial sponsored by Eli Lilly in participants with advanced cancer, including anal squamous cell carcinoma, head and neck squamous …
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung [Phase 2]
Phase 2 study comparing AXL1717 to docetaxel in non-small cell lung cancer has completed, including lung squamous cell carcinoma and lung ad…